Showing results (11-20 of 216) with videos related to
Sort By:
Pageof 22
British Journal of Pharmacology|November 26, 2021
Strategies towards safer opioid analgesics-A review of old and upcoming targetsBalazs R Varga, John M Streicher, Susruta MajumdarTrends in Pharmacological Sciences|January 18, 2025
Advances in the structural understanding of opioid allosteryNokomis Ramos-Gonzalez, Balazs R Varga, Susruta MajumdarAAPS Pharmscitech|June 1, 2012
Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal deliverySusruta Majumdar, Maren Mueller-Spaeth, Kenneth B SloanMethods in Molecular Biology (Clifton, N.J.)|August 12, 2015
Radioligand Binding Assay for an Exon 11-Associated Mu Opioid Receptor TargetGina F Marrone, Susruta Majumdar, Gavril W PasternakInternational Journal of Pharmaceutics|September 20, 2006
The effect of water solubility of solutes on their flux through human skin in vitroSusruta Majumdar, Joshua Thomas, Scott Wasdo, et al.Progress in Molecular Biology and Translational Science|August 10, 2010
Escorts take the lead molecular chaperones as therapeutic targetsDumaine Williams, Lakshmi A DeviFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 13, 2008
Regulation of CB1 cannabinoid receptor trafficking by the adaptor protein AP-3Raphael Rozenfeld, Lakshmi A DeviThe Mount Sinai Journal of Medicine, New York|August 1, 2006
The use of receptor-specific antibodies to study G-protein-coupled receptorsAchla Gupta, Lakshmi A DeviThe Biochemical Journal|December 17, 2010
Exploring a role for heteromerization in GPCR signalling specificityRaphael Rozenfeld, Lakshmi A DeviFASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2007
Receptor heterodimerization leads to a switch in signaling: beta-arrestin2-mediated ERK activation by mu-delta opioid receptor heterodimersRaphael Rozenfeld, Lakshmi A DeviPageof 22